MicroPulse® Transscleral Laser Therapy - Fluence May Explain Variability in Clinical Outcomes: A Literature Review

Tomas M Grippo1,2, Facundo G Sanchez1,3, Joan Stauffer4

  • 1Department of Glaucoma, Grippo Glaucoma & Cataract Center, Buenos Aires, Argentina.

Summary

MicroPulse® Transscleral Laser Therapy (MP-TLT) efficacy varies due to inconsistent parameters. Fluence, a new dose metric, may improve outcome prediction and treatment optimization for MP-TLT.